← Intervention Library

Foundations

Muscle preservation

Defending lean mass through mid and late life, rather than reacting to visible loss.

Nara’s current positionOwner-directed foundation
Evidence briefing

Strongest directness: Canine lifespan. Last reviewed 2026-08-12.

Nara’s evidence view

Owner-directed foundation

SupportedCanine lifespan outcomesModerate confidence

The claim we’re evaluating

Preserving lean mass and muscle function is a defensible canine aging goal because muscle mass declines with age and lower or declining lean mass is associated with adverse outcomes, but current evidence does not establish that a specific muscle-preservation intervention extends canine lifespan.

Nara’s interpretation

Nara considers preservation of muscle and physical function an important component of healthy canine aging. Canine studies show age-related muscle loss, and longitudinal data associate lower or declining lean mass with survival, but those associations do not prove that deliberately increasing muscle will extend life. Claims about specific exercise, protein, supplement, or rehabilitation strategies should therefore be assessed separately.

Personalized

What this means for your dog.

Loading your dog’s context…

Evidence briefing

What Nara knows now.

A bounded position while the full claim-level dossier is still being completed.

What is known

Older dogs have demonstrably lower muscle measurements than younger dogs in imaging studies, and clinical methods such as muscle-condition scoring can identify meaningful muscle loss. Longitudinal Labrador data link body composition, including lean-mass trajectories, with survival. Those studies establish aging associations and measurement validity more strongly than they establish causal benefit from a particular muscle-preserving intervention.

What is not known

Association between lean mass and survival does not establish that low lean mass is itself the causal driver of mortality. Muscle size or lean mass is not identical to strength, mobility, resilience, or other functional outcomes. The landmark longitudinal survival evidence is limited in breed diversity and sample size. Muscle-condition scoring and imaging measures have measurement limitations and are not interchangeable. Evidence for individual muscle-preservation interventions must not inherit the evidence rating of the broader muscle-preservation concept.

Current position

Nara considers preservation of muscle and physical function an important component of healthy canine aging. Canine studies show age-related muscle loss, and longitudinal data associate lower or declining lean mass with survival, but those associations do not prove that deliberately increasing muscle will extend life. Claims about specific exercise, protein, supplement, or rehabilitation strategies should therefore be assessed separately.

Older dogs have demonstrably lower muscle measurements than younger dogs in imaging studies, and clinical methods such as muscle-condition scoring can identify meaningful muscle loss. Longitudinal Labrador data link body composition, including lean-mass trajectories, with survival. Those studies establish aging associations and measurement validity more strongly than they establish causal benefit from a particular muscle-preserving intervention.